EPIDEMIOLOGY AND TREATMENT OF FUNGAL INFECTIONS IN ONCO-PEDIATRIC PATIENTS AT A REFERRAL HOSPITAL
DOI:
https://doi.org/10.46551/ruc.v23n2a04Palavras-chave:
: Fungal infections. Pediatrics. Cancer. TherapyResumo
Aim: to identify the epidemiology of fungal infections in the pediatric service of a reference hospital for the treatment of cancer for 2016 to 2019, through the dispensing of antifungal drugs by the hospital pharmacy. Methods: Retrospective cohort analysis of 1.211 antifungal requests. Results and Discussion: 1.211 treatments with antifungal agents were performed in the period, with 71.9% of cases treated with empirical therapy, 64.1% of cases of mucocutaneous candidiasis and with the use of nystatin in 48.6% of cases. There were 114 episodes of IFIs, in which probable fungal pneumonia represented 40.4% of the therapeutic
indications, based on suggestive tomographic images and clinical and epidemiological criteria in 40.3% of cases. Conclusions: There was an agreement between the epidemiology of fungal infections and the worldwide epidemiology, but there was disagreement between the therapies applied in the study hospital and the recent guidelines.
Downloads
Referências
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA (INCA). Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: 2019. Disponível em: <https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa2020-incidencia-de-cancer-no-brasil.pdf>. Acesso em: 09 Mar; 2020.
MINISTÉRIO DA SAÚDE. Protocolo de Diagnóstico Precoce do Câncer Pediátrico. Brasília, 2017. Disponível em:
<http://bvsms.saude.gov.br/bvs/publicacoes/protocolo_diagnostico_precoce_cancer_pediatrico.pdf>. Acesso em: 09 Mar. 2020.
RAMOS, J. T. et al. Clinical practice update of antifungal prophylaxis in immunocompromised children. Revista Espanola de Quimioterapia, Madri, v. 32, n. 5, p. 410– 425, 2019.
FRACCHIOLLA, N. S. et al. Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study. PLoS ONE, São Francisco. 14, n. 5, p. 1–14, 2019.
LAMOTH, F. et al. Changing epidemiology of invasive mold infections in patients receiving azole prophilaxis. Clin Infect Dis, Oxford 2017.
DE PAUW, B. et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive. Clin. Infect. Dis, Oxford, v. 46, n. 12, p. 1813–1821, 2008.
NIEDERHUBER, J. E. et al. Abeloff’s clinical oncology. 5 ed. Filadélfia: Elsevier, 2014.
BRANDI, A. C. M. B. Infecções fúngicas invasivas em crianças e adolescentes com câncer. 2019. 119p. Dissertação (Mestrado em Ciências) - Faculdade de Medicina, USP, São Paulo, 2019.
ASSOCIAÇÃO DE COMBATE AO CÂNCER EM GOIÁS (ACCG). Demonstrativo de Atividades de 2018. 2020. Relatório Anual da ACCG - ACCG, Goiânia.
SANTANA, L. R. et al. Perfil epidemiológico das Leucemias em Crianças e Adolescentes no Estado da Bahia. Gaz. méd. Bahia, Salvador, v. 77, n. 1, p.51-54, 2007.
CASTAGNOLA, E. et al. Fungal Infections in Children With Cancer: A Prospective, Multicenter Surveillance Study. Pediatr Infect Dis J, Filadélfia, v. 25, p. 634-639, 2006.
GROLL, A. H. et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol, Londres, v. 15, p. e327-40, 2014.
LEHRNBECHER, T. et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients:2017 Update. J Clin Oncol, Alexandria, v. 35, p.2082-2094, 2017.
MENEZES, A. C. et al. Abordagem clínica e terapêutica da mucosite oral induzida por radioterapia e quimioterapia em pacientes com câncer. Rev Bras Odontol, Rio de Janeiro, v. 71, n. 1, p.35-38, 2014.
COHEN-WOLKOWIEZ, M. et al. Pediatric antifungal agents. Curr Opin Infect Dis, Londres, v. 22, p. 553-558, 2009.
FLYNN, P. M. et al. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspesion versus nystatin. The Multicenter Fluconazole Study Group. J Pediatr, v. 127, n. 2, p. 322-
FILIPPIN, F. B., SOUZA, L. C. Eficiência terapêutica das formulações lipídicas de anfotericina B. Revista Brasileira de Ciências Farmacêuticas, São Paulo, v. 42, n. 2, p. 167-194, 2006.
BLYTH, C. C., PALASANTHIRAN P., O’BRIEN T. A. Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review. PEDIATRICS, v. 119, n. 4, p. 772-784, 2007.
